Product correctly added to cart.

discount label
S-Nitroso-N-propionyl-D,L-penicillamine
View 3D

Biosynth logo

S-Nitroso-N-propionyl-D,L-penicillamine

CAS: 225233-98-7

Ref. 3D-AJA23398

50mg
1,008.00 €
100mg
1,401.00 €
Estimated delivery in United States, on Wednesday 5 Mar 2025

Product Information

Name:
S-Nitroso-N-propionyl-D,L-penicillamine
Description:

S-Nitroso-N-propionyl-D,L-penicillamine is a nitric oxide donor that can be used in the treatment of locomotor activity and renal injury. It has been shown to inhibit protein synthesis and growth factor production by light exposure. This drug has also been used to treat infectious diseases such as tuberculosis, as well as autoimmune diseases like lupus and lymphoproliferative disorders such as leukemia. S-Nitroso-N-propionyl-D,L-penicillamine is also used for the prevention of postoperative kidney damage after ischemia reperfusion during surgery. The drug was found to reduce the levels of neutrophils, which are cells that are responsible for inflammation. There have been no reports on its potential carcinogenicity or mutagenicity.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
234.28 g/mol
Formula:
C8H14N2O4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-AJA23398 S-Nitroso-N-propionyl-D,L-penicillamine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".